ePT--the Electronic Newsletter of Pharmaceutical Technology, Jun 30, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Jun 30, 2011
News
Obama Initiates Partnership to Reinvigorate Manufacturing
By Erik Greb
President Obama unveiled an Advanced Manufacturing Partnership designed to reinvigorate the country's manufacturing sector.
IPEC Federation Issues Statement of Phthalate Use
By Patricia Van Arnum
The IPEC Federation has issued a statement on the use of phthalates in pharmaceutical products in response to reports of adulteration of certain nutritional supplements, vitamins, foods, and beverages imported from Taiwan.
EMA Stakeholder Forum on Pharmacovigilance
By Rich Whitworth
The European Medicines Agency (EMA) has held a second forum regarding the implementation of new pharmacovigilance legislation, which gave stakeholders the opportunity to discuss their expectations on various aspects of the new legislation's execution.
Pharma R&D Concerns
By Stephanie Sutton
Industry analysts have highlighted the pharma industry's high rate of Phase III drug terminations and significantly reduced R&D spending.
Week of June 27, 2011: Company and People Notes: Roche Establishes R&D Institute in France; Sanofi Appoints Peter Guenter as Senior Vice-President, Europe; and More.
Roche Establishes R&D Institute in France; Sanofi Appoints Peter Guenter as Senior Vice-President, Europe; and More.
Regulatory Roundup: FDA Publishes Final Guidance on Dissolution Testing
FDA Publishes Final Guidance on Dissolution Testing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here